Effect of 0.01% Atropine on Choroidal Thickness and Ocular Growth in Pre-myopic Children
Authors:
- 8 April 2026
- journal article
- research article
- Published by Springer Nature in Ophthalmic and Physiological Optics
- Vol. 46 (2) , 386-394
Abstract
Purpose To investigate the effect of nightly 0.01% atropine eye drops on choroidal thickness (ChT) in pre-myopic children (at risk of myopia). Methods In a 12-month randomised, double-blind, placebo-controlled trial, 54 children aged 5–12 received nightly 0.01% atropine or placebo in both eyes. ChT was measured in 15 macular sectors using swept-source OCT at baseline and every 3 months. Longitudinal mixed-effects models (LMM) compared ChT changes between groups, and an unsupervised clustering analysis of individual ChT trajectories was performed. Results Both groups showed progressive choroidal thinning. At 12 months, atropine-treated eyes showed a trend towards less choroidal thinning than placebo, especially in the central, inferior and temporal macular areas, but between-group differences did not reach statistical significance after multiple comparison correction. Clustering of ChT trajectories revealed two exploratory clusters: a “Thinning-dominant” pattern with pronounced mid-year thinning (6–9 months) followed by partial recovery by month 12 and a “Stable ChT” pattern with minimal change. Eyes in the Thinning-dominant group had faster axial elongation than the Stable group, suggesting an association between ΔChT clusters and ocular growth. Conclusions Nightly low-dose atropine in pre-myopic children showed a non-significant trend toward reduced macular choroidal thinning. Clustering and early-change analyses revealed heterogeneity in ChT responses and exploratory associations with ocular growth. These findings require external validation and do not support early ΔChT as a clinically actionable treatment–response marker.Keywords
Funding Information
- Tianjin Education Commission Social Science (2022JWZD23)
This publication has 48 references indexed in Scilit:
- Silhouette coefficient-based weighting k-means algorithmNeural Computing and Applications, 2024
- The Macular Choroidal Thickness in Danish Children with Myopia After Two-Year Low-Dose Atropine and One-Year Wash-Out: A Placebo-Controlled, Randomized Clinical TrialOphthalmology and Therapy, 2024
- Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia ControlJAMA Ophthalmology, 2023
- Prevention of myopia shift and myopia onset using 0.01% atropine in premyopic children — a prospective, randomized, double-masked, and crossover trialEuropean Journal of Pediatrics, 2023
- Effect of Low-Concentration Atropine Eyedrops vs Placebo on Myopia Incidence in ChildrenJAMA, 2023
- Efficacy in myopia controlProgress in Retinal and Eye Research, 2021
- Side effects of topical atropine 0.05% compared to 0.01% for myopia control in German school children: a pilot studyInternational Ophthalmology, 2021
- Changes in Choroidal Thickness Varied by Age and Refraction in Children and Adolescents: A 1-Year Longitudinal StudyAmerican Journal of Ophthalmology, 2020
- Efficacy and Adverse Effects of Atropine in Childhood MyopiaJAMA Ophthalmology, 2017
- The multifunctional choroidProgress in Retinal and Eye Research, 2010